推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Future Oncology

2023年12月最新中科院分区表数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

按期刊名首写字母查看 FUTURE ONCOL最新评论：快3个星期了，还是under consideratio。你现在怎么样？ (2024-03-14)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看：


Future Oncology期刊基本信息Hello，您是该期刊的第52928位访客


基本信息 登录收藏
期刊名字Future OncologyFuture Oncology

FUTURE ONCOL
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
6.6
52人评分
我要评分

声誉
7.6

影响力
5.2

速度
9.1

期刊ISSN1479-6694
微信扫码收藏此期刊
E-ISSN1744-8301
2022-2023最新影响因子
（数据来源于搜索引擎）		3.3 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日：2.899
2022-2023自引率3.00%点击查看自引率趋势图
五年影响因子3.2
h-index 60
CiteScore
CiteScoreSJRSNIPCiteScore排名
5.200.8740.759
学科分区排名百分位
大类：Medicine
小类：Oncology		Q2155 / 366
大类：Medicine
小类：Cancer Research		Q3124 / 214

期刊简介
Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.

The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.
期刊官方网站http://www.futuremedicine.com/loi/fon
期刊投稿网址http://www.futuremedicine.com/page/submitarticle
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Future Oncology的语言要求，还能让Future Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Future Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（1篇） 。
提交文稿
是否OA开放访问No
通讯方式FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
出版商Future Medicine Ltd.
涉及的研究方向ONCOLOGY-
出版国家或地区ENGLAND
出版语言English
出版周期Monthly
出版年份2005
年文章数 298点击查看年文章数趋势图
Gold OA文章占比38.00%
研究类文章占比：
文章 ÷（文章 + 综述）		82.55%
WOS期刊SCI分区
（ 2022-2023年最新版）		WOS分区等级：3区

按学科分区JIF分区JIF排名JIF百分位
学科：ONCOLOGY
类别：SCIE		Q3135/241
中科院《国际期刊预警
名单（试行）》名单 		2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中科院SCI期刊分区
（ 2023年12月最新升级版） 		点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区4区1区
ONCOLOGY
肿瘤学		4区1区4区
否否
中科院SCI期刊分区
（ 2022年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
ONCOLOGY
肿瘤学		2区3区4区
否否
中科院SCI期刊分区
（ 2021年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 2区4区4区
ONCOLOGY
肿瘤学		4区1区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1479-6694%5BISSN%5D
平均审稿速度网友分享经验：
偏慢,4-8周
平均录用比例网友分享经验：
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Future Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Future Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Future Oncology中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Future Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE616630
    BIOMATERIALS524467
    BIOMEDICINE & PHARMACOTHERAPY481207
    Journal of Materials Chemistry B468337
    Frontiers in Pharmacology463627
    Frontiers in Immunology436643
    JOURNAL OF ETHNOPHARMACOLOGY417579
    COLLOIDS AND SURFACES B-BIOINTERFACES411142
    Frontiers in Oncology395146
    COMPUTERS IN BIOLOGY AND MEDICINE387510
  •  

    Future Oncology Future Oncology
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Value of biomarkers in epithelial-mesenchymal transition models of liver cancer under different interventions: a meta-analysis

    Author: Yan, Jing; Xie, Bei; Zou, Shuli; Huang, Li; Tian, Ye; Li, Jing; Peng, Zhiheng; Liu, Zhuan; Ma, Bin; Li, Linjing
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 36, pp. 4031-4045. DOI: 10.2217/fon-2022-0344        PubMed      DOI
    2.The roles of IDH1 in tumor metabolism and immunity

    Author: Ni, Yingqian; Shen, Peibo; Wang, Xingchen; Liu, He; Luo, Huiyuan; Han, Xiuzhen
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 35, pp. 3941-3953. DOI: 10.2217/fon-2022-0583        PubMed      DOI
    3.Preoperative assessment of high-grade endometrial cancer using a radiomic signature and clinical indicators

    Author: Zheng, Tao; Pan, Jiangyang; Du, Dan; Liang, Xin; Yi, Huiling; Du, Juan; Wu, Shuo; Liu, Lanxiang; Shi, Gaofeng
    Journal: FUTURE ONCOLOGY. 2023; Vol. 19, Issue 8, pp. 587-601. DOI: 10.2217/fon-2022-0631        PubMed      DOI
    4.A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial

    Author: Lu, Sheng; Chen, Yi-Gang; Liu, Xiao-Wen; Yang, Zhong-Yin; Shi, Min; Yuan, Hong; Liu, Wen-Tao; Ni, Zhen-Tian; Yao, Xue-Xin; Hua, Zi-Chen; Feng, Run-Hua; He, Chang-Yu; Zheng, Ya-Nan; Wang, Zhen-Qiang; Sah, Birendra Kumar; Chen, Ming-Min; Zhu, Zheng-Lun; Li, Chen; Zhang, Jun; Yan, Min; Xia, Jia-Zeng; Zhu, Zheng-Gang; Yan, Chao
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 39, pp. 4239-4249. DOI: 10.2217/fon-2022-0718        PubMed      DOI
    5.Receptor discordance among primary tumors, brain metastases and extra-brain metastases in patients with breast cancer

    Author: Wang, Qian; Guo, Zhoubo; Huang, Zhou; Sun, Huiru; Zhu, Jingyang; Shi, Jinyan; Zhang, Wencheng; Li, Desheng; Sun, Bing
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 37, pp. 4101-4110. DOI: 10.2217/fon-2022-0498        PubMed      DOI
    6.Psychological distress as risk factor for the efficacy of whole-brain radiotherapy in brain metastasis patients

    Author: Li, Wen; Gan, Chen; Zuo, He; Yin, Xiangxiang; Jing, Yanyan; Pang, Lulian; Yu, Sheng; Tang, Lingxue; Yao, Senbang; Cheng, Huaidong
    Journal: FUTURE ONCOLOGY. 2023; Vol. 19, Issue 1, pp. 49-60. DOI: 10.2217/fon-2022-0690        PubMed      DOI
    7.Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study

    Author: Li, Sheng; Liu, Xiaoqiang; Liu, Weipeng; Fu, Bin
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 38, pp. 4171-4181. DOI: 10.2217/fon-2022-0843        PubMed      DOI
    8.Esophageal stenosis as an independent factor of poor prognosis in patients with ESCC treated with definitive chemoradiotherapy

    Author: Gui, Zhongxuan; Hu, Wenjun; Kong, Qi; Liu, Can; Xu, Yuechen; Wang, Fan
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 38, pp. 4193-4207. DOI: 10.2217/fon-2022-0125        PubMed      DOI
    9.A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data

    Author: Cheema, Parneet; Cho, Byoung Chul; Freitas, Helano; Provencio, Mariano; Chen, Yuh Min; Kim, Sang-We; Wu, Yi-Long; Passaro, Antonio; Martin, Claudio; Tiseo, Marcello; Chang, Gee-Chen; Park, Keunchil; Solomon, Benjamin; Burghuber, Otto; Laskin, Janessa; Wang, Ziping; Lee, Sung Yong; Hu, Yanping; Vansteenkiste, Johan; Zhang, He-long; Hanrahan, Emer; Geldart, Thomas; Taylor, Rosemary; Servidio, Leslie; Li, Jingyi; de Marinis, Filippo
    Journal: FUTURE ONCOLOGY. 2023; Vol. 19, Issue 1, pp. 61-75. DOI: 10.2217/fon-2022-0919        PubMed      DOI
    10.KEYNOTE-991: pembrolizumab plus enzalutamide and androgen deprivation for metastatic hormone-sensitive prostate cancer

    Author: Gratzke, Christian; Kwiatkowski, Mariusz; Giorgi, Ugo De; Martins da Trindade, Karine; De Santis, Maria; Armstrong, Andrew J.; Niu, Cuizhen; Liu, Yingjie; Poehlein, Christian Heinrich
    Journal: FUTURE ONCOLOGY. 2023; Vol. 18, Issue 37, pp. 4079-4087. DOI: 10.2217/fon-2022-0776        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    HARVARD BUSINESS REVIEW02.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.10
    Energy Material Advances08.50
    CLINICAL AND EXPERIMENTAL HYPERTENSION453.60
    Journal of Public Transportation07.00
    Asian Journal of Psychiatry010.90
    Chinese Journal of Population Resources and Environment02.60
    VIEW08.60
    HLA933.00
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY011.50


以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

    同领域作者分享投稿经验：共167条 （包含回复）

 我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

    增值电信业务经营许可证：沪B2-20211595

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451